ZNF555

gene
On this page

Also known as MGC26707

Summary

ZNF555 (zinc finger protein 555, HGNC:28382) is a protein-coding gene on chromosome 19p13.3, encoding Zinc finger protein 555 (Q8NEP9). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 148254 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 89 total
  • MANE Select transcript: NM_152791

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28382
Approved symbolZNF555
Namezinc finger protein 555
Location19p13.3
Locus typegene with protein product
StatusApproved
AliasesMGC26707
Ensembl geneENSG00000186300
Ensembl biotypeprotein_coding
Entrez148254

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 5 protein_coding

ENST00000334241, ENST00000585966, ENST00000591539, ENST00000905416, ENST00000940323

RefSeq mRNA: 2 — MANE Select: NM_152791 NM_001172775, NM_152791

CCDS: CCDS12096, CCDS59329

Canonical transcript exons

ENST00000334241 — 4 exons

ExonStartEnd
ENSE0000133761228514682851651
ENSE0000133761528523802860471
ENSE0000133761628414752841575
ENSE0000360080728505872850713

Expression profiles

Bgee: expression breadth ubiquitous, 234 present calls, max score 92.98.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.0725 / max 81.5612, expressed in 1645 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1731285.07521602
1731290.9973616

Top tissues by expression

248 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
amniotic fluidUBERON:000017392.98gold quality
secondary oocyteCL:000065592.56gold quality
oocyteCL:000002392.08gold quality
spermCL:000001987.85gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099186.91gold quality
buccal mucosa cellCL:000233682.15gold quality
cortical plateUBERON:000534380.00gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.46gold quality
cartilage tissueUBERON:000241878.38gold quality
ventricular zoneUBERON:000305377.40gold quality
esophagus squamous epitheliumUBERON:000692077.18gold quality
ganglionic eminenceUBERON:000402376.01gold quality
islet of LangerhansUBERON:000000675.17gold quality
corpus callosumUBERON:000233674.13gold quality
stromal cell of endometriumCL:000225573.92gold quality
adrenal tissueUBERON:001830372.80gold quality
calcaneal tendonUBERON:000370172.77gold quality
endometriumUBERON:000129572.61gold quality
medial globus pallidusUBERON:000247772.25gold quality
lower esophagus mucosaUBERON:003583472.20gold quality
leukocyteCL:000073871.77gold quality
monocyteCL:000057671.59gold quality
left ovaryUBERON:000211971.35gold quality
ovaryUBERON:000099271.27gold quality
heart left ventricleUBERON:000208470.93gold quality
cardiac ventricleUBERON:000208270.87gold quality
globus pallidusUBERON:000187570.72gold quality
smooth muscle tissueUBERON:000113570.62gold quality
uterusUBERON:000099570.58gold quality
hindlimb stylopod muscleUBERON:000425270.37gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no5.18

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

156 targeting ZNF555, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-4455100.0065.481587
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-6748-5P100.0065.811057
HSA-MIR-4533100.0069.482758
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-150-5P99.9966.691976
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-453499.9966.581907
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-453199.9969.703181
HSA-MIR-428299.9975.366408
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-477599.9875.006394
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-314899.9775.066478
HSA-MIR-365899.9673.874379
HSA-MIR-146A-5P99.9668.93988
HSA-MIR-146B-5P99.9669.13977
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-570-3P99.9672.414910
HSA-MIR-808299.9567.271170
HSA-MIR-7153-5P99.9468.891006
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-4778-3P99.9370.401818

Literature-anchored findings (GeneRIF, showing 1)

  • Identification of ZNF555 as a putative transcriptional factor highly expressed in human primary myoblasts that interacts with the beta-satellite repeats enhancer site and impacts the ANT1 promoter activity in facioscapulohumeral dystrophy myoblasts. (PMID:26184877)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
mus_musculusZfp78ENSMUSG00000055150
rattus_norvegicusENSRNOG00000083797
drosophila_melanogasterCG2712FBGN0024975
drosophila_melanogasterPhsFBGN0036522
drosophila_melanogasterCG3281FBGN0260741

Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF70 (ENSG00000187792)

Protein

Protein identifiers

Zinc finger protein 555Q8NEP9 (reviewed: Q8NEP9)

All UniProt accessions (2): Q8NEP9, K7ENK0

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (3)

UniProt IDNamesCanonical?
Q8NEP9-11yes
Q8NEP9-22
Q8NEP9-43

RefSeq proteins (2): NP_001166246, NP_690004* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050752C2H2-ZF_domainFamily

Pfam: PF00096, PF01352, PF13894

UniProt features (25 total): zinc finger region 15, sequence variant 4, splice variant 3, chain 1, domain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NEP9-F168.780.06

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 57 (showing top): ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, PEDRIOLI_MIR31_TARGETS_UP, ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES, CREB3L4_TARGET_GENES, LHX9_TARGET_GENES, OVOL3_TARGET_GENES, PHF21A_TARGET_GENES, PRKDC_TARGET_GENES, SALL4_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

368 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF555SPATA31E1Q6ZUB1505
ZNF555MALRD1Q5VYJ5422
ZNF555CYLC2Q14093418
ZNF555FANK1Q8TC84417
ZNF555ZNF474Q6S9Z5393
ZNF555SPMIP9Q96LM6376
ZNF555SPATA24Q86W54376
ZNF555SPATC1Q76KD6370
ZNF555TRIM28Q13263366
ZNF555MOSPD1Q9UJG1358
ZNF555ZC3H6P61129357
ZNF555CACNA1BQ00975353
ZNF555SPATA3Q8NHX4349
ZNF555DCUN1D5Q9BTE7348
ZNF555CBY2Q8NA61325

IntAct

15 interactions, top by confidence:

ABTypeScore
CCNDBP1ZNF555psi-mi:“MI:0915”(physical association)0.670
ZNF555CCNDBP1psi-mi:“MI:0915”(physical association)0.670
ZNF555KRTAP10-7psi-mi:“MI:0915”(physical association)0.560
ZNF555CEP70psi-mi:“MI:0915”(physical association)0.560
KRTAP10-7ZNF555psi-mi:“MI:0915”(physical association)0.560
CEP70ZNF555psi-mi:“MI:0915”(physical association)0.560
TRIM28ZNF316psi-mi:“MI:0914”(association)0.530
NOTCH2ZNF320psi-mi:“MI:0914”(association)0.350
LTBP2ZNF320psi-mi:“MI:0914”(association)0.350
ZNF555HERC1psi-mi:“MI:0914”(association)0.350

BioGRID (16): ZNF555 (Two-hybrid), ZNF555 (Two-hybrid), KRTAP10-7 (Two-hybrid), FAM73A (Affinity Capture-MS), MTCL1 (Affinity Capture-MS), HERC1 (Affinity Capture-MS), ZNF555 (Affinity Capture-RNA), HERC1 (Affinity Capture-MS), FAM73A (Affinity Capture-MS), MTCL1 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS)

ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21

Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

89 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance79
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

660 predictions. Top by Δscore:

VariantEffectΔscore
19:2841573:ATGGT:Adonor_loss1.0000
19:2841574:TGGTG:Tdonor_loss1.0000
19:2841575:GGTG:Gdonor_loss1.0000
19:2841576:G:Cdonor_loss1.0000
19:2850579:T:TAacceptor_gain1.0000
19:2850582:TTTA:Tacceptor_loss1.0000
19:2850583:TTA:Tacceptor_loss1.0000
19:2850585:A:AGacceptor_gain1.0000
19:2850585:A:Gacceptor_loss1.0000
19:2850585:AG:Aacceptor_gain1.0000
19:2850586:G:GAacceptor_gain1.0000
19:2850586:GG:Gacceptor_gain1.0000
19:2850709:AGTAG:Adonor_loss1.0000
19:2850710:GTAG:Gdonor_gain1.0000
19:2850711:TAG:Tdonor_gain1.0000
19:2850714:G:GGdonor_gain1.0000
19:2850714:GTA:Gdonor_loss1.0000
19:2850715:T:Gdonor_loss1.0000
19:2851459:T:TAacceptor_gain1.0000
19:2851466:A:AGacceptor_gain1.0000
19:2851467:G:GGacceptor_gain1.0000
19:2852379:GTA:Gacceptor_gain1.0000
19:2841576:G:GGdonor_gain0.9900
19:2850577:ATT:Aacceptor_gain0.9900
19:2850583:TTAGG:Tacceptor_gain0.9900
19:2850584:TAGG:Tacceptor_gain0.9900
19:2850585:A:Tacceptor_gain0.9900
19:2850586:G:Cacceptor_gain0.9900
19:2850586:GGA:Gacceptor_gain0.9900
19:2850586:GGAC:Gacceptor_gain0.9900

AlphaMissense

4170 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:2852858:T:CF265L0.996
19:2852860:C:AF265L0.996
19:2852860:C:GF265L0.996
19:2852942:T:CF293L0.995
19:2852944:T:AF293L0.995
19:2852944:T:GF293L0.995
19:2853026:T:CF321L0.993
19:2853028:C:AF321L0.993
19:2853028:C:GF321L0.993
19:2852690:T:CF209L0.992
19:2852692:T:AF209L0.992
19:2852692:T:GF209L0.992
19:2853278:T:CF405L0.992
19:2853280:C:AF405L0.992
19:2853280:C:GF405L0.992
19:2852774:T:CF237L0.991
19:2852776:T:AF237L0.991
19:2852776:T:GF237L0.991
19:2853110:T:CF349L0.990
19:2853112:C:AF349L0.990
19:2853112:C:GF349L0.990
19:2853194:T:CF377L0.990
19:2853196:C:AF377L0.990
19:2853196:C:GF377L0.990
19:2853362:T:CF433L0.990
19:2853364:C:AF433L0.990
19:2853364:C:GF433L0.990
19:2852715:G:CR217P0.989
19:2853446:T:CF461L0.988
19:2853448:C:AF461L0.988

dbSNP variants (sampled 300 via entrez): RS1000217973 (19:2849236 C>T), RS1000291602 (19:2849025 G>C), RS1000318270 (19:2843256 T>G), RS1000387075 (19:2856166 T>C), RS1000464593 (19:2844310 C>G,T), RS1000578112 (19:2860944 G>T), RS1000623978 (19:2840275 A>G), RS1000736240 (19:2860638 T>G), RS1000794461 (19:2851511 G>C), RS1000830284 (19:2841775 T>C), RS1001075682 (19:2845777 T>C), RS1001301210 (19:2850323 C>T), RS1001402534 (19:2846073 C>T), RS1001498567 (19:2848832 A>C), RS1001653640 (19:2855211 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST003518_101Daytime sleep phenotypes8.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007828daytime rest measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

30 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, decreases expression, increases expression6
trichostatin Aaffects cotreatment, decreases expression3
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Cadmium Chlorideincreases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
TAK-243increases sumoylation1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
sodium arsenitedecreases expression1
vanadyl sulfatedecreases expression1
diethyl malateincreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrineincreases expression1
dorsomorphinaffects cotreatment, decreases expression1
jinfukangdecreases expression1
Acetaminophenincreases expression1
Air Pollutantsaffects expression, increases abundance1
Azathioprineincreases expression1
Doxorubicindecreases expression1
Formaldehydedecreases expression1
Ozoneaffects expression, increases abundance1
Phthalic Acidsincreases methylation1
Quercetindecreases expression1
Tetrachlorodibenzodioxinaffects expression1
Tobacco Smoke Pollutionincreases expression1
Cyclosporineincreases expression1
Copper Sulfateincreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_XW63HEK293 eGFP-ZNF555Transformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.